Inovio Pharmaceuticals CMV Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study

News   Nov 28, 2012

 
Inovio Pharmaceuticals CMV Synthetic Vaccine Constructs Generate Strong and Broad T-Cell Responses in Preclinical Study
 
 
 

RELATED ARTICLES

Patent Plausability Case Sees BIA Intervention

News

The UK Bioindustry Association (BIA) will intervene in a court case which could have huge ramifications for UK bioscience.

READ MORE

Pioneering Method Enables Screening Millions of Human Antibodies for Rapid Therapeutic Discovery

News

A paper just published in Nature Biotechnology outlines a pioneering method of screening a person's diverse set of antibodies for rapid therapeutic discovery.

READ MORE

The BuzzBuster: Could Gene Silencing Help Silence the Housefly?

News

Gene silencing dsRNA technology can reduce housefly fertility, showing promise as a pest-control method.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE